Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participants

Author:

Huang Yunda123ORCID,Zhang Lily1,Eaton Amanda4,Mkhize Nonhlanhla N.5,Carpp Lindsay N.1ORCID,Rudnicki Erika1,DeCamp Allan1,Juraska Michal1,Randhawa April1,McDermott Adrian6,Ledgerwood Julie6,Andrew Philip7,Karuna Shelly1,Edupuganti Srilatha8,Mgodi Nyaradzo9,Cohen Myron1011,Corey Lawrence112,Mascola John6,Gilbert Peter B.113,Morris Lynn5,Montefiori David C.4

Affiliation:

1. Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

2. Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

3. Department of Global Health, University of Washington, Seattle, Washington, USA

4. Duke Human Vaccine Institute, Department of Surgery, Duke University, Durham, North Carolina, USA

5. National Institute for Communicable Diseases, Johannesburg, South Africa

6. Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA

7. Family Health International, Durham, North Carolina, USA

8. Division of Infectious Diseases, Department of Medicine, Emory University, Decatur, Georgia, USA

9. Clinical Trials Research Centre, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe

10. Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA

11. Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina, USA

12. Departments of Medicine and Laboratory Medicine, University of Washington, Seattle, Washington, USA

13. Department of Biostatistics, University of Washington, Seattle, Washington, USA

Funder

National Institute of Allergy and Infectious Disease of the National Institutes of Health

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3